These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21424920)

  • 21. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiac resynchronization therapy for mild heart failure: the time has come.
    Reynolds CR; Gold MR
    Circulation; 2011 Jan; 123(2):195-202. PubMed ID: 21242505
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac resynchronization therapy for treatment of heart failure.
    Ho JK; Mahajan A
    Anesth Analg; 2010 Dec; 111(6):1353-61. PubMed ID: 21059745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac resynchronization therapy: is systole all that matters?
    Biffi M; Bertini M; Boriani G
    Europace; 2010 Sep; 12(9):1209-10. PubMed ID: 20551047
    [No Abstract]   [Full Text] [Related]  

  • 25. Finding pieces of the puzzle of nonresponse to cardiac resynchronization therapy.
    Gorcsan J
    Circulation; 2011 Jan; 123(1):10-2. PubMed ID: 21173347
    [No Abstract]   [Full Text] [Related]  

  • 26. Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study.
    Gasparini M; Steinberg JS; Arshad A; Regoli F; Galimberti P; Rosier A; Daubert JC; Klersy C; Kamath G; Leclercq C
    Eur Heart J; 2010 Apr; 31(8):976-83. PubMed ID: 20071325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
    Tang WH; Francis GS
    Circulation; 2011 Jan; 123(2):203-8. PubMed ID: 21242506
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply: application of the gompertz method for evaluating survival gains in patients receiving cardiac resynchronization therapy.
    Finegold JA; Francis DP
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2879-80. PubMed ID: 24814493
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of heart rate recovery after exercise stress test: implications for cardiac resynchronization therapy.
    Merkely B; Roka A
    Europace; 2011 Apr; 13(4):458-9. PubMed ID: 21208946
    [No Abstract]   [Full Text] [Related]  

  • 30. Reducing operator radiation exposure during cardiac resynchronization therapy.
    Brambilla M; Occhetta E; Ronconi M; Plebani L; Carriero A; Marino P
    Europace; 2010 Dec; 12(12):1769-73. PubMed ID: 21097481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing atrioventricular and interventricular intervals following cardiac resynchronization therapy.
    Nayar V; Khan FZ; Pugh PJ
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):185-97. PubMed ID: 21453215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biventricular pacemaker optimization guided by comprehensive echocardiography-preliminary observations regarding the effects on systolic and diastolic ventricular function and third heart sound.
    Taha N; Zhang J; Ranjan R; Daneshvar S; Castillo E; Guillen E; Montoya MC; Velasquez G; Naqvi TZ
    J Am Soc Echocardiogr; 2010 Aug; 23(8):857-66. PubMed ID: 20510584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart failure patients selection for cardiac resynchronization therapy.
    Geng J; Wu B; Zheng L; Zhu J
    Eur J Intern Med; 2011 Feb; 22(1):32-8. PubMed ID: 21238890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization for New York Heart Association class IV patients.
    Geng J; Zhu J
    Europace; 2010 Dec; 12(12):1797; author reply 1797-8. PubMed ID: 20876275
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute effects of cardiac resynchronization therapy on breathing during sleep in patients with severe chronic heart failure--a pilot study].
    Duchna HW; Orth M; Karschuck P; Schultze-Werninghaus G; Lawo T
    Pneumologie; 2008 Apr; 62(4):189-95. PubMed ID: 18200454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac resynchronization therapy: can left ventricular lead position make the difference?
    Gomes R; Santos JM; Abecasis J; Fartouce S; Morgado F; Adragão P; Silva A
    Rev Port Cardiol; 2010 Oct; 29(10):1569-74. PubMed ID: 21265495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All cause mortality of cardiac resynchronization therapy with implantable cardioverter defibrillator: a meta-analysis of randomized controlled trials.
    Huang Y; Wu W; Cao Y; Qu N
    Int J Cardiol; 2010 Dec; 145(3):413-7. PubMed ID: 20541819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulation of the phrenic nerve as an alternative to left ventricular lead repositioning in cardiac resynchronization therapy.
    van Steenberghe M; Pruvot E; Delay D; Delacretaz E; Ruchat P
    Int J Cardiol; 2011 Mar; 147(2):328-9. PubMed ID: 21256608
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent advances in cardiac resynchronization therapy.
    Steffel J; Holzmeister J; Abraham WT
    Postgrad Med; 2011 Mar; 123(2):18-26. PubMed ID: 21474889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is it time to expand the use of cardiac resynchronization therapy to patients with mildly symptomatic heart failure?
    Exner DV
    J Am Coll Cardiol; 2009 Nov; 54(20):1847-9. PubMed ID: 19800192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.